Is respiratory care your priority for 2021?

Subscribe to our mailing list to be notified about new updates
Summary: Structured medicine reviews are an incentivised element of the 2020/2021 NHS England plan. What is your local implementation plan? Have you considered respiratory and specifically medicines optimisation of patients with COPD on multiple medicines as part of your local plan? Alongside a downloadable PDF poster, this brief article outlines the evidence to support the case for a focus on respiratory care and the associated medicines optimisation opportunity in COPD. It includes scenarios comparing spend reduction in triple therapy and impact on environmental emissions. In addition, data is presented on overall respiratory spend and variation by NHS England region.

Thank you for your interest in this article. You need to register in order to be able to continue reading. Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article. You need to register in order to be able to continue reading.

Thank you for your interest in this article. You need to register in order to be able to continue reading. Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article.

Thank you for your interest in this article. You need to register in order to be able to continue reading. Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article.

Thank you for your interest in this article. You need to register in order to be able to continue reading. Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article.

Register or log in to read this article

In order to continue reading you will need to sign-up to Value.GSK

Register

Already have an account?
Log in

About your author:

Author Name

Dr. Alun Griffith
Evidence Generation Manager at GSK

Alun joined GSK in 2009 following training as a Health Economist at York University and consultancy experience preparing health economic materials and regulatory submissions. In his current role he collaborates with the NHS by simplifying access to key evidence in respiratory care and supporting the publication of local case studies.

close